TriSalus Life Sciences, Inc. ($TLSI)
Filing Information
| Accession Number | 0001628280-26-020190 |
|---|---|
| Form Type | 4 |
| Filing Date | Mar 20, 2026 |
| Document | View SEC Filing |
Transactions
3
Total Shares
3,207
Total Value
$13,171.30
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Chief of Clinical Operations | Common Stock | โ | Mar 11, 2026 | Sale | 1,162 | $4.13 | $4,799.06 | 99,409 | Direct | โ | View Details | |
Chief of Clinical Operations | Common Stock | โ | Mar 12, 2026 | Sale | 1,772 | $4.09 | $7,247.48 | 97,637 | Direct | โ | View Details | |
Chief of Clinical Operations | Common Stock | โ | Mar 16, 2026 | Sale | 273 | $4.12 | $1,124.76 | 97,364 | Direct | โ | View Details |